海目星(688559.SH):目前形成交貨和量產的是準固態電池,電解液含量低於10%
格隆匯5月15日丨海目星(688559.SH)在互動平台表示,公司在固態電池領域已進行了長期的研發工作,涉及半固態、準固態 到全固態電池的三個基礎技術路線。 目前形成交貨和量產的是準固態電池,電解液含量低於10%,該技術路線已有中試產線進行量產,已經得到了行業的認可和客户的使用,能量密度超過 480 瓦時/公斤,循環次數超過400次,據客户反饋,我們是目前行業裏唯一一條達到480瓦時/公斤的產線。我們的技術路線採用氧化物固態電解質和金屬鋰作為負極。目前客户對於公司合作開發的設備很滿意,並且後期不排除在公司生產基地附近建廠。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.